Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.05M Buy
53,500
+47,100
+736% +$8.21M 0.7% 59
2025
Q4
$1.04M Sell
6,400
-700
-10% -$105K 0.07% 80
2025
Q3
$962K Buy
+7,100
New +$1.01M 0.08% 78
2024
Q2
Sell
-53,470
Closed -$10.6M 133
2024
Q1
$10.6M Buy
53,470
+200
+0.4% +$36.6K 0.5% 73
2023
Q4
$9.27M Hold
53,270
0.64% 71
2023
Q3
$8.33M Sell
53,270
-1,200
-2% -$199K 0.57% 75
2023
Q2
$8.93M Buy
54,470
+400
+0.7% +$58.4K 0.63% 70
2023
Q1
$8.35M Buy
+54,070
New +$8.6M 0.49% 77

Other funds holding NUE

Payden & Rygel's NUE Position: Q1 2026 in Review

Payden & Rygel increased its Nucor (NUE) stake by 736% in Q1 2026, buying an estimated $8.21M and bringing the position to 53,500 shares worth $9.05M. The position accounts for 0.7% of the portfolio, ranked #59.

Payden & Rygel first reported a position in NUE in Q1 2023 and has held it in 8 quarters since. The position peaked at $10.6M in Q1 2024. 1,370 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Payden & Rygel held 53,500 shares of Nucor worth $9.05M as of Q1 2026.
  • Payden & Rygel bought 47,100 Nucor shares in Q1 2026, an estimated $8.21M.
  • Nucor made up 0.7% of Payden & Rygel's portfolio in Q1 2026, its #59 holding.
  • Payden & Rygel first reported a position in Nucor in Q1 2023 and has held it in 8 quarters since.
  • Payden & Rygel's Nucor position peaked at $10.6M in Q1 2024.
  • 1,370 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.